Presentations

Day 1

From Burden to Benefit: Transforming Publication Management Is Easier Than You Think
Wallace Holland - Chief Operating Officer, BP Logix
Peter Herout - Associate Director of Scientific Communications, Esperion Therapeutics

How AI/ML Can Impact Medical Affairs
Nathan Lear - Head, Advanced Analytics and Clinical Trial Efficiency, AstraZeneca

Measuring and Conveying the Value of Medical Affairs
Dr. Diana Morgenstern - Executive Strategist, Medical Affairs, IQVIA
Javier Lopez-Molina - Senior Director, Medical Strategy, Medical Affairs, IQVIA

Measuring Medical Impact: The Journey From Lofty Concept to Real World Execution
Christine Medeiros - Sr. Director, Strategic Insights, H1

Quantifying Impact: Unveiling Metrics That Resonate with Stakeholders
Daniel Snyder, Ph.D. - Senior Vice President, Medical Affairs, BioPharma & Women’s Health, Sumitomo Pharma America, Inc.

Reimagining Medical Content Development for the Era of High-Speed, Snackable Scientific Exchange
Tim Mitchell, Ph.D. - Managing Director, Medical Communications & Innovation, Klick
Rachael Harrison, Ph.D. - Vice President of Science and Regulatory, Klick

Day 2 - Tracks

Medical Communications

Keynote: Mapping the Medical Communication Landscape: Strategies for Seamless Collaboration from Pipeline to Launch
Poushali Mukherjea - Vice President Medical Affairs Pipeline, Alnylam Pharmaceuticals

Agile Scientific Communications in Medical Affairs: From Pandemic Pressure to Generative AI
Rachel Kennedy, Ph.D. - Senior Director, Head of Scientific Communications, Moderna
Mary Bausch-Jurken, Ph.D. - Global Scientific Communications Lead COVID-19, Moderna

Plain Language and Patient-Centric Communication: The Importance of the Patient Voice
Alia Bucciarelli - Senior Director, Medical Operations, Vertex Pharmaceuticals
Brian Scheckner, PharmD - Senior Director, Medical Communications, Neuroscience Franchise Global Medical Affairs, Jazz Pharmaceuticals
Dakota Fisher-Vance - Associate Director, Global Patient Advocacy, BioCryst Pharmaceuticals
Lori Neri, ANP, CMPP - Director of Scientific Communication, Global Medical Affairs, Insmed Incorporated
Sashi Nadanaciva, DPhil - Director, Global Medical Affairs Oncology, Publications, Daiichi Sankyo

The Digital Renaissance of Scientific Communication: Embracing Technological Breakthroughs
Sonia A. Schweers, PharmD - Director, Medical Policy & Governance | Global Medical Excellence & Policy, Bristol Myers Squibb
Sarah Guadagno, Ph.D. - Founder and Principal, 8X Life Science Communications
Daina Nanchanatt, PharmD - Director, Oncology Scientific Communications, Bayer
Christine Wyble - Head Scientific Communication & Field Medical, Novartis

The Science Behind Emotions
Priyanka Patel, PharmD - Managing Director, Medical, BGB Group
Anka Gorgiev, Ph.D. - Senior Vice President, Brand Strategy, BGB Group
Jon Nelson - Mental Illness Survivor & Patient Advocate

Transformative Applications of Generative AI Analytics: Optimizing Next Best Actions and Assessing Medical Team Impact
Stephanie Otis - Vice President of US Medical Affairs, Ferring Pharmaceuticals
Badal Shah, B.Pharm, M.S., M.B.A. - Founder & President, Neolytica – A QPharma Company

Medical Affairs Strategy

Keynote: Synergizing Strategies: Uniting Medical Affairs Through Language and Vision
Debbie Bensen-Kennedy - Vice President, North America Medical Affairs, CSL Behring

Unlocking the Power of Real-World Evidence to Pave the Way for Better Patient Outcomes
Howard Dorfman - Founder, H.L. Dorfman Pharmaceutical Consulting, LLC
Pranav Abraham, Ph.D. - Medical Evidence Strategy Leader, Global Medical Affairs, Rare Diseases, Sanofi
Christine Lemke - Co-Founder and CEO, Evidation
Felix Lee - US Digital Healthcare Medical Head, Sanofi
Michael Doane, Ph.D. - Senior Director, Head of Health Economics and Outcomes Research (HEOR), Alkermes
Kimberly Barnholt, Ph.D - Executive Director, Evidence Generation Leader, US Medical Affairs, Genentech

Leveraging Foundational Analytics Platforms to Demonstrate Medical Affairs Impact
Lori Klein - Partner, Medical & Scientific Affairs Practice Lead, Putnam

The Pivotal Role in Ensuring Access to Innovative Products: New Normal for Medical Affairs
Siddharth Jain, MD. - Medical Director (Global Medical Lead, HAE & LSDs), Takeda


MSL Best Practices

Keynote: Recognizing Your Impact in Field Medical: Learnings from Big Pharma and a Start-Up Environment
Mike Sopko - National Director of Field Medical, Zambon

Strategic Field Medical Engagement: Building a Robust Plan for Successful Launch in Medical Affairs
Craig Klinger, R.Ph. - Former Director - Global MSL Trainer, The Office of Medical Professional Development, Eli Lilly and Company
Mike Durkin - Regional Director, Medical Science Liaisons, Blueprint Medicines
Carolyn Reever, PhD - Global Head, Neuropsychiatry Medical Affairs, Biogen
Suzanne Giordano, Ph.D. - Associate Vice President, Head of Field Medical, Axsome Therapeutics

Empowering Your Field Medical Team: Strategies for Optimizing in the Omnichannel Era
Chad Schroer - Senior Director, US Medical Affairs, Field Medical Excellence, BeiGene USA, Inc.
Stacey Gorski, PhD - Head, US Medical Excellence, AstraZeneca
Donnie Wooten Jr. Pharm.D. - Global Head Strategic Medical Content & Omnichannel, Organon
Annie Herrington, PharmD - Vice President, Field Medical Excellence Platform Lead Medical Engagement & Impact, Pfizer

From Insights to Impact: The Power of Thought Leader Liaisons and Medical Science Liaisons in Compliant Collaboration for Meaningful Customer Engagement
Jim Hahn - Senior Business Director, Thought Leader Liaisons, EMD Serono
Lindsay Harrer - Senior Business Director, East Thought Leader Liaisons U.S. Neurology & Immunology, EMD Serono

Business is Not a Dirty Word for MSL’s
Conner Blaine Hampton PharmD, RPh. - Director, National Accounts, Pharmacosmos Therapeutics Inc.
Varun Nagpal, Ph.D. - US Regional Director Medical Affairs - Global Thoracic Oncology - Global Medical & Scientific Affairs, Merck
Edmund H. Doherty - Senior Consultant and Founder, Blue Jay Medical Affairs Consulting, LLC.
Megan Grosso - Head of US Medical Affairs, Amylyx Pharmaceuticals
Lori Lebson, Ph.D. - Senior Vice President North America Medical Affairs, EMD Serono

Building Medical Capabilities by Design
Mary Winkels, PharmD - Global Director, Medical Affairs Training and Capability, Vertex Pharmaceuticals

Day 3 - Workshops

Morning Workshop A - Thrive, not just survive, through change
Jill Fenwick, Ph.D. - Global Head of Medical Learning, EMD Serono
Shannon Colton - Founder and Consultant, MarbleWing Consulting
Ian Casci - Director, Medical Excellence and Training, Pharmacosmos Therapeutics Inc.

Morning Workshop B- Cracking the Code: Strategies for Communicating the Impact of Medical Affairs
Renu Juneja, Ph.D. - Head, Scientific Evidence & Communications, Oncology US Medical Affairs, Johnson & Johnson
Linda Traylor, Ph.D. - Vice President, Head of Medical Excellence, Acceleration Point

Afternoon Workshop C - Medical Science Liaison Compliance Essentials : A Workshop for Success in the US
Mary Winkels, PharmD - Global Director, Medical Affairs Training and Capability, Vertex Pharmaceuticals
Adeola Davis - Director of Learning and Development, Medical Affairs, Acadia Pharmaceutical

Afternoon Workshop D - “Once upon a time in medical affairs…”: How storytelling fits into communicating data – the numbers don’t speak for themselves
Jill Fenwick, Ph.D. - Global Head of Medical Learning, EMD Serono
Shannon Colton - Founder and Consultant, MarbleWing Consulting
Ian Casci - Director, Medical Excellence and Training, Pharmacosmos Therapeutics Inc.